BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats. Neuroscience Letters 2016;617:201-6. [DOI: 10.1016/j.neulet.2016.02.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Fakhari M, Azizi H, Semnanian S. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons. Neuroscience 2017;363:1-10. [DOI: 10.1016/j.neuroscience.2017.08.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Aghajani N, Pourhamzeh M, Azizi H, Semnanian S. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats. Neurosci Lett 2021;755:135909. [PMID: 33892002 DOI: 10.1016/j.neulet.2021.135909] [Reference Citation Analysis]
3 Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence. J Pharmacol Exp Ther 2019;371:422-52. [PMID: 31391211 DOI: 10.1124/jpet.119.258004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
4 Downs AM, Mcelligott ZA. Noradrenergic circuits and signaling in substance use disorders. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.108997] [Reference Citation Analysis]
5 Hooshmand B, Azizi H, Javan M, Semnanian S. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats. Neuroscience Letters 2017;636:276-81. [DOI: 10.1016/j.neulet.2016.10.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
6 Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides 2020;124:170223. [DOI: 10.1016/j.peptides.2019.170223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A, Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fundam Clin Pharmacol 2017;31:201-7. [DOI: 10.1111/fcp.12249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Sahafzadeh M, Karimi-Haghighi S, Mousavi Z, Haghparast A. Role of the orexin receptors within the nucleus accumbens in the drug priming-induced reinstatement of morphine seeking in the food deprived rats. Brain Res Bull 2018;137:217-24. [PMID: 29258865 DOI: 10.1016/j.brainresbull.2017.12.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
9 Davoudi M, Vijeepallam K, Azizi H, Mirnajafi-Zadeh J, Semnanian S. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal. J Neural Transm (Vienna) 2019;126:1425-35. [PMID: 31493096 DOI: 10.1007/s00702-019-02064-2] [Reference Citation Analysis]
10 Han Y, Yuan K, Zheng Y, Lu L. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders. Neurosci Bull 2020;36:432-48. [PMID: 31782044 DOI: 10.1007/s12264-019-00447-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
11 Kourosh-arami M, Javan M, Semnanian S. Inhibition of orexin receptor 1 contributes to the development of morphine dependence via attenuation of cAMP response element-binding protein and phospholipase Cβ3. Journal of Chemical Neuroanatomy 2020;108:101801. [DOI: 10.1016/j.jchemneu.2020.101801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal. J Physiol Sci 2019;69:281-93. [DOI: 10.1007/s12576-018-0645-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ahmadi-soleimani SM, Azizi H, Gompf HS, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology 2017;126:25-37. [DOI: 10.1016/j.neuropharm.2017.08.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
14 Rezamohammadi F, Rahmani M, Ghanbari A, Khaleghian A, Miladi-Gorji H. BDNF receptor antagonism during the induction of morphine dependence exacerbates the severity of physical dependence and ameliorates psychological dependence in rats. Neurosci Lett 2020;737:135332. [PMID: 32860885 DOI: 10.1016/j.neulet.2020.135332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kargar HM, Azizi H, Mirnajafi-zadeh J, Mani AR, Semnanian S. Orexin A presynaptically decreases inhibitory synaptic transmission in rat locus coeruleus neurons. Neuroscience Letters 2018;683:89-93. [DOI: 10.1016/j.neulet.2018.06.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fatemi I, Hadadianpour Z, Fatehi F, Shamsizadeh A, Hasanshahi J, Abbasifard M, Kaeidi A. The role of locus coeruleus nucleus TRPV1 receptors in the development and expression of morphine dependence. Iran J Basic Med Sci 2019;22:1186-91. [PMID: 31998461 DOI: 10.22038/ijbms.2019.35055.8338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 al'Absi M, Lemieux A, Hodges JS, Allen S. Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse. Addict Biol 2019;24:743-53. [PMID: 30117237 DOI: 10.1111/adb.12643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]